Back
Enanta Pharmaceuticals Stock Price Chart
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Sell
34
ENTA
Enanta Pharmaceuticals
Last Price:
12.34
Seasonality Move:
-6.03%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing slight selling pressure.
Enanta Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.11 | Sell |
| 20-day SMA: | 15.1 | Sell |
| 50-day SMA: | 14.74 | Sell |
| 200-day SMA: | 12.85 | Sell |
| 8-day EMA: | 13.3 | Sell |
| 20-day EMA: | 14.31 | Sell |
| 50-day EMA: | 14.29 | Sell |
| 200-day EMA: | 16.47 | Sell |
Enanta Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 30.84 | Sell |
| Chaikin Money Flow: | -17012 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.59 - 16.85) | Sell |
| Bollinger Bands (100): | (10.53 - 15.21) | Sell |
Enanta Pharmaceuticals Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 12.37 while ENTA 8-day simple moving average is 13.11, which is a Sell signal.
- The stock price of ENTA is 12.37 while Enanta Pharmaceuticals 20-day SMA is 15.10, which makes it a Sell.
- Enanta Pharmaceuticals 50-day simple moving average is 14.74 while ENTA share price is 12.37, making it a Sell technically.
- ENTA stock price is 12.37 and Enanta Pharmaceuticals 200-day simple moving average is 12.85, creating a Sell signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
34
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a Sell
The current Enanta Pharmaceuticals [ENTA] share price is $12.37. The Score for ENTA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
261.7M
Price in USD:
12.37
Share Volume:
67K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
37.75
52-Week Low:
8.08
Sell
34
Enanta Pharmaceuticals (ENTA)
is a Sell
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?
The Enanta Pharmaceuticals stock price is 12.37 USD today. -
Will ENTA stock go up or go down?
Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Enanta Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 12.37 while ENTA 8-day exponential moving average is 13.30, which is a Sell signal.
- The stock price of ENTA is 12.37 while Enanta Pharmaceuticals 20-day EMA is 14.31, which makes it a Sell.
- Enanta Pharmaceuticals 50-day exponential moving average is 14.29 while ENTA share price is 12.37, making it a Sell technically.
- ENTA stock price is 12.37 and Enanta Pharmaceuticals 200-day simple moving average is 16.47, creating a Sell signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.16 per share, an increase this year of $1.86 per share, and an increase next year of $0.05 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
- ENTA Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Enanta Pharmaceuticals is a Sell
- Enanta Pharmaceuticals Relative Strength Index (RSI) is 30.84, which suggest Enanta Pharmaceuticals is oversold
- The Bollinger Bands (25) for Enanta Pharmaceuticals is (13.59 - 16.85), which suggest Enanta Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Enanta Pharmaceuticals is (10.53 - 15.21), which suggest Enanta Pharmaceuticals is a Sell
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.